C86.51 Angioimmunoblastic T-cell lymphoma, in remission

Billable ICD-10-CM code, FY2026. Acts as a Complication or Comorbidity (CC) as a secondary diagnosis.

Applicable to

• Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), in remission

Applies from C86 Other specified types of T/NK-cell lymphoma

Excludes1 (never code together)

• anaplastic large cell lymphoma, ALK negative (C84.7-)
• anaplastic large cell lymphoma, ALK positive (C84.6-)
• mature T/NK-cell lymphomas (C84.-)
• other specified types of non-Hodgkin lymphoma (C85.8-)

Applies from C86.5 Angioimmunoblastic T-cell lymphoma

Applicable to

• Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD)

Risk adjustment (HCC)

• CMS-HCC V28: HCC 19 — Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers
• CMS-HCC V22: HCC 10 — Lymphoma and Other Cancers
• RxHCC V08: HCC 21 — Lymphomas and Other Hematologic Cancers
• ESRD V24: HCC 10

MS-DRG index

Defines the logic of DRG(s) 820-822 in MDC 17.

Code annotations containing back-references to C86.51

Back-references to C86

• Type 1 Excludes: C76 Malignant neoplasm of other and ill-defined sites ("malignant neoplasm of lymphoid, hematopoietic and related tissue (C81-C96)")
• Type 1 Excludes: C77 Secondary and unspecified malignant neoplasm of lymph nodes ("malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)")
• Type 1 Excludes: C85 Other specified and unspecified types of non-Hodgkin lymphoma ("other specified types of T/NK-cell lymphoma (C86.-)")
• Code First: Z15.0 Genetic susceptibility to malignant neoplasm (", if applicable, any current malignant neoplasm (C00-C75, C81-C96)")

Nearby codes

• C86.4 Blastic NK-cell lymphoma
• C86.40 Blastic NK-cell lymphoma not having achieved remission
• C86.41 Blastic NK-cell lymphoma, in remission
• C86.5 Angioimmunoblastic T-cell lymphoma
• C86.50 Angioimmunoblastic T-cell lymphoma not having achieved remission
• C86.51 Angioimmunoblastic T-cell lymphoma, in remission (this code)
• C86.6 Primary cutaneous CD30-positive T-cell proliferations
• C86.60 Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
• C86.61 Primary cutaneous CD30-positive T-cell proliferations, in remission